The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
Open accessAbstract
The influence of fibrinogen on the risk of cardiovascular disease is examined over 16 years of follow-up in 1314 subjects who were initially free of cardiovascular disease in the Framingham Study. Of these subjects, 46 men and 43 women developed diabetes, and 56 men and 53 women had blood sugar levels that exceeded 120 mg/dl. Diabetes predisposed subjects to all of the 408 major cardiovascular disease outcomes. Diabetics had higher levels of fibrinogen, hypertension, hypertriglyceridemia, and obesity, but lower HDL cholesterol values. The influence of diabetes on cardiovascular disease was greatly dependent on these coexistent risk factors, but there was a substantial independent effect of glucose intolerance when all the standard risk factors had been taken into account. There was a rise in fibrinogen values throughout the range of blood sugar levels, which suggests a thrombogenic explanation for the unique diabetic effect. However, multivariate analysis indicates no further reduction in diabetic cardiovascular risk ratios after adjustment for fibrinogen; thus, there is a residual effect for glucose intolerance after all of the standard risk factors and fibrinogen have been taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Self-citationFibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Diabetes and cardiovascular risk factors: the Framingham study
Kannel, W. B., & McGee, D. L. (1979) · Circulation · doi:10.1161/01.cir.59.1.8 · Cited by 1,317
Self-citationFibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Self-citationHÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY
Meade, T. W., Chakrabarti, R., Haines, A. P., North, W. R. S., Stirling, Y., Thompson, S. G., & Brozović, M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91498-1 · Cited by 690
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study
Kannel, W. B. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90224-8 · Cited by 665
Self-citationFibrinogen and risk of cardiovascular disease
Nguyen, V. (1988) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(88)80530-4 · Cited by 593
GORDON, T., CASTELLI, W. P., HJORTLAND, M. C., KANNEL, W. B., & DAWBER, T. R. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-4-393 · Cited by 368
Self-citationLetter: Sterilisation of cardiac bioptome.
Maddocks, A. C. (1974) · PubMed · Cited by 322
Increased Plasma Fibrinogen and Platelet-Aggregates in Type II Hyperlipoproteinaemia
Lowe, G. D. O., Drummond, M. M., Third, J. L. H. C., Bremner, W. F., Forbes, C. D., Prentice, C. R. M., & Lawrie, T. D. V. (1979) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657051 · Cited by 72
Cited by
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Self-citationIs Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality
Fox, C. S., Sullivan, L., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.704 · Cited by 317
Self-citationMüller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
Metadata
- Authors
- Kannel, W. B., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., & Gagnon, D. R.
- Venue
- American Heart Journal
- Publisher
- Elsevier BV
- Published
- 1990-09
- Volume
- 120
- Issue
- 3
- Pages
- 672-676
- ISSN
- 0002-8703 (ISSN-L)
- OpenAlex
- W2019631323
- Cited by
- 368
- References
- 12
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. https://app.cochat.ai/papers/10.1016/0002-8703(90)90026-t
- The paper
- Kannel, W. B., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., & Gagnon, D. R. (1990). Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. American Heart Journal. https://doi.org/10.1016/0002-8703(90)90026-t
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.